公众号 / 文章呼吸衰竭与机械通气重症综合管理与镇静镇痛

淋巴管肌瘤病一氧化碳弥散量的演变:历史视角与先进影像的作用

Evolution of Diffusing Capacity of the Lungs for Carbon Monoxide in Lymphangioleiomyomatosis: Historical Perspectives and the Role of Advanced Imaging.
PubMed 文献 · Chest · 2024-11-21
一句话结论在淋巴管肌瘤病中,DLCO与FEV1反映不同病变:大囊主要影响FEV1,小囊主要影响DLCO,DLCO的作用可能被低估。

本文为综述,梳理淋巴管肌瘤病(LAM)中一氧化碳弥散量(DLCO)与FEV1的历史演变及当前应用。LAM组织学评分与疾病分期相关,且与DLCO的一致性高于FEV1;高分辨率CT囊肿评分与疾病进展相关。高分辨率CT所见大囊主要影响FEV1,而小囊影响更大肺表面积、可能被低估,倾向于影响DLCO。文章还讨论西罗莫司治疗背景下DLCO与FEV1的应用及肺功能变化速率的监测,并强调现代影像方法对理解LAM进展的贡献及DLCO独特而可能被低估的作用。

要点

  • LAM组织学评分与疾病分期相关,且与DLCO的一致性高于FEV1。
  • 高分辨率CT囊肿评分衡量囊肿占据的肺实质,与疾病进展相关。
  • 高分辨率CT所见大囊主要影响FEV1,小囊倾向于影响DLCO。
  • LAM中FEV1与DLCO是常用评估指标,但疾病可能以其中一项变化为主。
  • 文章讨论西罗莫司治疗背景下DLCO与FEV1的应用及肺功能变化速率监测。

适用人群与场景

  • 淋巴管肌瘤病(LAM)女性患者,累及肺、肾和淋巴系统。

研究设计与关键结果

  • 综述梳理LAM中DLCO与FEV1从早期与组织病理学特征及影像关系研究到当前应用的历史演变。
  • LAM组织学评分通过活检衡量囊肿和LAM细胞在肺内的累及,与疾病分期相关,且与DLCO的一致性高于FEV1。
  • 高分辨率CT计算的囊肿评分衡量囊肿占据的肺实质,与疾病进展相关。
  • 高分辨率CT所见大囊主要影响FEV1,而小囊影响更大肺表面积、可能被低估,倾向于影响DLCO。
  • 文章讨论西罗莫司治疗背景下DLCO与FEV1的应用及肺功能变化速率的监测。
  • 文章聚焦现代影像方法对理解LAM进展的贡献,并强调DLCO独特而可能被低估的作用。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease affecting women and is characterized by the proliferation of abnormal smooth muscle-like cells within the lungs, kidneys, and lymphatic system. FEV1 and diffusing capacity of the lungs for carbon monoxide (Dlco) are 2 commonly used markers for evaluating the status of LAM, although the disease may be associated predominantly with changes in only 1 of these parameters. In this special feature, we trace the historical evolution of Dlco and FEV1 in LAM up to their current uses, beginning with their relationship in early studies with histopathologic features and imaging. We transition to the use of Dlco and FEV1 in the context of sirolimus therapy and monitoring rates of change in lung function. Finally, we examine modern imaging methods and how these techniques have contributed to our understanding of LAM progression, with a focus on the unique and perhaps undervalued role of Dlco. The LAM histologic score, which measures the involvement of cysts and LAM cells in the lung via biopsy, relates to disease stages and aligns more with Dlco than FEV1. The cyst score, calculated from high-resolution CT scans, is a measure of the lung parenchyma occupied by cysts and correlates with disease progression. Large cysts as visualized by high-resolution CT imaging predominantly influence FEV1, whereas smaller cysts, which impact a greater surface area of the lung and may be underestimated, tend to affect Dlco.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Yang BE, Elinoff JM, Campbell-Washburn AE, et al. Evolution of Diffusing Capacity of the Lungs for Carbon Monoxide in Lymphangioleiomyomatosis: Historical Perspectives and the Role of Advanced Imaging. Chest. 2024. PMID: 39580110. doi:10.1016/j.chest.2024.11.014

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。